Free Drug Pricing For Poland In 1977

23 June 1996

The Polish government's economic committee recommended earlier this month that the full cabinet should free pharmaceutical prices in 1997, according to a report from Reuters. A government press statement said that for an intermediate period after freeing drug prices, the Finance Ministry would implement mechanisms which would prevent large, one-off jumps in drug prices.

The committee also stressed the need for quicker privatization of the Polish pharmaceutical industry, and said its production should be protected by duties on finished drug imports. In addition, it suggested that Poland should keep duty-free quotas for drug raw materials until 2000.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight